Test Background
Lamotrigine (brand name Lamicital) is indicated for use singularly and in adjunctive treatment of partial epileptic seizures, as well as primary and secondary tonic-clonic seizures. Also used as a mood stabiliser in bipolar disorders.
Clinical Indications
Assessment of patient compliance Assessment of suspected toxicity
Reference Range
| See report |
Sample Required
SST (gold top), serum (red top) or saliva (red top)
Sample Volume
1 mL pre-dose trough sample
Turnaround Time
Up to 6 weeks
Notes
Not currently performed in house; this is a referred test.